Octreotide treatment of patients with hepatocellular carcinoma - a retrospective single centre controlled study [PDF]
Journal of Experimental & Clinical Cancer Research, 2009 Background Studies of treatment with octreotide of patients with hepatocellular carcinoma (HCC) gave conflicting results. We analyzed retrospectively the survival of our patients treated with octreotide monotherapy and compared it to stage-matched ...
Müller Christian +3 more
doaj +2 more sources
Comparative analysis of adverse event profiles of lanreotide and octreotide in somatostatin-responsive endocrine and neoplastic diseases [PDF]
Scientific ReportsLanreotide and Octreotide are used to treat various endocrine and neoplastic diseases. This study aims to compare the adverse event profiles of Lanreotide and Octreotide in somatostatin-responsive diseases using FAERS data.
Le Wang +3 more
doaj +2 more sources
Octreotide in the therapy of recurrent medulloblastomas [PDF]
Archive of Oncology, 2006 BACKGROUND: Recurrence of medulloblastoma appears after 30% to 40% of the surgeries. Different from primary medulloblastoma, in which five-year survival rate is 50%, the survival time of relapses much shorter and only 20% of the patients manage to ...
Stefanović Ivan +3 more
doaj +3 more sources
Pathophysiology, 2023 Acromegaly is a condition most commonly diagnosed in the fifth decade of life and has numerous treatment options. In this regard, Mycapssa® is the first FDA-approved oral octreotide capsule for treating acromegaly, combining the efficacy of the ...
Charles P. Daniel +9 more
doaj +1 more source
Use of octreotide for prevention of pancreatic leak after pancreatoduodenectomy: study progress [PDF]
Waike lilun yu shijian, 2022 The pancreatic leak after pancreaticoduodenectomy was one of the main causes of postoperative death, the rate of which remained high. Octreotide, an octapeptide somatostatin analogue, has been used in the prevention and treatment of postoperative ...
XU Yu, ZHANG Junfeng, HUA Rong
doaj +1 more source
Octreotide in the treatment of acromegaly – the possibilities of high-dose therapy
Медицинский совет, 2022 Octreotide is a first-generation somatostatin analog that has been used for 40 years for the medical treatment of acromegaly, both after neurosurgical intervention and as first-line treatment.
I. A. Ilovayskaya
doaj +1 more source
Effect of Octreotide Injection on Postoperative Drainage After Neck Dissection: A Preliminary Report of a Prospective, Matched Case-Control Study [PDF]
Clinical and Experimental Otorhinolaryngology, 2016 Objectives Somatostatin inhibits lymph production and reduces lymph flow into the lymphatic duct. We hypothesized that octreotide, a long-acting somatostatin analog, would reduce drainage after neck dissection (ND) by reducing the overall lymphatic flow ...
Dongbin Ahn +3 more
doaj +1 more source
Necrotizing enterocolitis as a side effect of octreotide in a preterm neonate, a case report
Journal of Pediatric Surgery Case Reports, 2022 Congenital chylous ascites (CCA) is a rare disease, characterized by accumulation of chyle in the peritoneal cavity in infants
Nasim Rabiee +5 more
doaj +1 more source
Scientific Reports, 2023 Octreotide, a somatostatin analogue, has shown its efficacy for the diagnostics and treatment of various types of cancer, i.e., in octreotide scan, as radio-marker after labelling with a radiopharmaceutical.
Jonas Lins +10 more
doaj +1 more source
Current diagnosis and treatment of acute pancreatitis in China: a real-world, multicenter study
BMC Gastroenterology, 2021 Background Efficacy of pancreatic enzyme inhibitors in acute pancreatitis (AP) is unclear in China. Aims We aimed to present the current status of AP and evaluate the efficacy of pancreatic enzyme inhibitors in a larger population in China.
Chuandong Sun +3 more
doaj +1 more source